Lyell Immunopharma reported total assets of $273.85M and total liabilities of $81.13M for the quarter ended Sep 2026, down 32.9% year over year. This balance sheet covers 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 293.83M | 222.60M | 205.74M | 116.31M | 123.55M | 109.43M | 224.37M | 286.21M | 145.65M | 125.65M | 133.42M | 100.30M | 105.60M | 120.33M | 98.80M | 123.58M | 60.18M | 90.77M | 72.99M | 92.05M | ||||||
| Short-term InvestmentsInvestments (Current) | 320.97M | 391.32M | 449.83M | 531.82M | 516.60M | 503.34M | 371.38M | 289.22M | 400.58M | 400.65M | 357.70M | 340.25M | 264.93M | 180.85M | 177.99M | 196.05M | 187.04M | 163.25M | 131.12M | 85.05M | ||||||
| Cash & Current Investments | 614.79M | 613.91M | 655.56M | 648.13M | 640.15M | 612.77M | 595.75M | 575.43M | 546.22M | 526.30M | 491.12M | 440.55M | 370.53M | 301.18M | 276.79M | 319.62M | 247.22M | 254.02M | 204.10M | 177.11M | ||||||
| Prepaid Assets | 11.49M | 11.79M | 11.21M | 11.61M | 11.14M | 11.63M | 10.66M | 11.42M | 8.46M | 7.87M | 8.71M | 9.50M | 9.07M | 8.00M | 5.42M | 8.58M | 13.72M | 13.28M | 9.44M | 9.11M | ||||||
| Current Assets | 626.29M | 625.71M | 666.78M | 659.75M | 651.30M | 624.40M | 606.41M | 586.85M | 554.69M | 534.17M | 499.82M | 450.05M | 379.59M | 309.18M | 282.21M | 328.20M | 260.94M | 267.30M | 213.54M | 186.21M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 120.10M | 125.71M | 127.56M | 125.73M | 123.02M | 118.60M | 113.68M | 108.10M | 102.65M | 97.84M | 93.10M | 88.05M | 48.20M | 44.20M | 39.12M | 36.72M | 34.77M | 32.72M | 30.51M | 28.53M | ||||||
| Long-Term Investments | 283.53M | 224.12M | 131.44M | 102.52M | 70.12M | 55.26M | 36.95M | 32.00M | 32.00M | 19.00M | 19.00M | 20.11M | 19.00M | 28.95M | 20.06M | 19.00M | 19.00M | 19.00M | 23.90M | 19.00M | ||||||
| Long-Term Deferred Tax | ||||||||||||||||||||||||||
| Other Non-Current Assets | 0.47M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.29M | 0.29M | 0.29M | 6.31M | 1.69M | 1.58M | 1.59M | 6.47M | 6.82M | 7.43M | 7.50M | ||||||
| Non-Current Assets | 501.12M | 446.40M | 354.90M | 317.52M | 286.27M | 256.05M | 228.94M | 208.14M | 195.34M | 160.06M | 154.32M | 169.17M | 111.27M | 120.62M | 103.24M | 79.76M | 79.11M | 83.32M | 97.61M | 87.64M | ||||||
| Assets | 1,127.41M | 1,072.10M | 1,021.67M | 977.27M | 937.56M | 880.45M | 835.35M | 794.99M | 750.03M | 694.22M | 654.14M | 619.22M | 490.86M | 429.80M | 385.45M | 407.97M | 340.05M | 350.63M | 311.15M | 273.85M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 3.21M | 6.51M | 4.25M | 4.80M | 3.92M | 5.73M | 5.81M | 4.37M | 4.82M | 4.90M | 4.20M | 3.60M | 5.37M | 3.73M | 3.38M | 2.57M | 2.89M | 5.47M | 3.88M | 4.04M | ||||||
| Payables | 3.21M | 6.51M | 4.25M | 4.80M | 3.92M | 5.73M | 5.81M | 4.37M | 4.82M | 4.90M | 4.20M | 3.60M | 5.37M | 3.73M | 3.38M | 2.57M | 2.89M | 5.47M | 3.88M | 4.04M | ||||||
| Accumulated Expenses | 29.06M | 22.69M | 21.40M | 23.57M | 28.76M | 22.42M | 24.83M | 29.65M | 28.13M | 24.91M | 25.67M | 29.01M | 40.82M | 31.17M | 28.00M | 29.31M | 46.52M | 31.48M | 35.99M | 42.24M | ||||||
| Current Deferred Revenue | 4.99M | 6.22M | 15.43M | 11.19M | ||||||||||||||||||||||
| Total Current Liabilities | 46.74M | 41.06M | 50.29M | 51.22M | 37.03M | 30.80M | 34.39M | 35.06M | 34.52M | 32.35M | 30.88M | 33.51M | 53.79M | 41.29M | 36.90M | 31.88M | 49.41M | 36.95M | 39.87M | 46.27M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Non-Current Deferred Revenue | 79.67M | 77.87M | 32.93M | 37.16M | ||||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||
| Operating Leases | 66.65M | 67.48M | 66.07M | 64.64M | 63.17M | 61.83M | 60.22M | 58.58M | 56.89M | 55.16M | 53.32M | 51.44M | 50.99M | 48.85M | 46.60M | 44.29M | 41.92M | 39.49M | 36.93M | 34.32M | ||||||
| Other Non-Current Liabilities | 4.57M | 4.45M | 4.34M | 4.23M | 4.11M | 4.00M | 3.89M | 3.78M | 3.66M | 3.55M | 3.44M | 3.57M | 10.85M | 9.53M | 8.56M | 2.68M | 0.52M | 0.53M | 0.54M | 0.55M | ||||||
| Total Non-Current Liabilities | 193.05M | 186.40M | 149.29M | 153.02M | 100.20M | 92.62M | 94.61M | 93.64M | 91.41M | 87.51M | 84.20M | 84.95M | 97.18M | 83.75M | 77.98M | 76.16M | 91.33M | 76.43M | 76.80M | 80.59M | ||||||
| Total Liabilities | 197.62M | 190.85M | 153.63M | 157.24M | 104.31M | 96.62M | 98.50M | 97.42M | 95.08M | 91.06M | 87.64M | 88.52M | 108.04M | 93.28M | 86.53M | 78.84M | 91.85M | 76.96M | 77.34M | 81.13M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Common Equity | 929.79M | 881.25M | 868.04M | 820.03M | 833.25M | 783.83M | 736.86M | 697.57M | 654.95M | 603.16M | 566.50M | 530.70M | 382.82M | 336.52M | 298.92M | 329.12M | 248.20M | 273.67M | 233.82M | 192.72M | ||||||
| Liabilities and Shareholders Equity | 1,127.41M | 1,072.10M | 1,021.67M | 977.27M | 937.56M | 880.45M | 835.35M | 794.99M | 750.03M | 694.22M | 654.14M | 619.22M | 490.86M | 429.80M | 385.45M | 407.97M | 340.05M | 350.63M | 311.15M | 273.85M | ||||||
| Retained Earnings | -584.36M | -652.51M | -688.83M | -759.08M | -767.48M | -834.44M | -898.33M | -949.18M | -1,002.11M | -1,062.78M | -1,108.59M | -1,153.17M | -1,345.11M | -1,397.30M | -1,439.99M | -1,478.83M | -1,619.55M | -1,643.71M | -1,688.46M | -1,733.99M |
Pull Lyell Immunopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=LYEL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "LYEL", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=LYEL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();